Jul. 19 2010
Source Page: Guidance on commissioning cancer services: improving outcomes in gynaecological cancers. The manual. Incl. appendices. 85 p.Found: Guidance on commissioning cancer services: improving outcomes in gynaecological cancers.
Laid - 6 Mar 2024 In Force 1 Apr 2024
These Regulations amend the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 (S.I. 2012/2996) (“the Standing Rules”). They are made under the National Health Service Act 2006 (c. 41) (“the 2006 Act”), as amended by the Health and Care Act 2022 (c. 31) …
Found: National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing
Jan. 11 2024
Source Page: Waiting times for suspected and diagnosed cancer patients for November 2023Found: Waiting times for suspected and diagnosed cancer patients for November 2023
Found: and about cancer services, inc luding the views of patients and carers. 2.
Asked by: John Hayes (Conservative - South Holland and The Deepings)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make a comparative estimate of breast cancer survival rates in (a) the UK and (b) other comparable nations in the latest period for which data is available.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
There are no such plans to make a comparative assessment. Cancer survival is measured in cohorts, so the 2010 comparison point uses the 2006-10 cohort, compared to the latest available data which reflects the 2016-20 cohort. In England, breast cancer net survival rate for the 2016-20 cohort one year after diagnosis was 96.1% compared to 94.4% for the 2006-10 cohort. The five-year survival rate was 85.9% for the 2016-20 cohort compared to 83.2% for the 2006-10 cohort.
The Department has undertaken analyses previously, especially of comparative cancer survival rates and contributors to variations between different countries. However, the different factors and methods used in such analyses are very complex and subject to interpretation of issues such as public health, risk factors, and patient pathways.
An example of this can be seen in the Department’s evidence to the Health and Social Care Select Committee Inquiry into cancer services, submitted and published in September 2021. More information is available at the following link:
https://committees.parliament.uk/writtenevidence/39021/pdf/
Mentions:
1: Yousaf, Humza (SNP - Glasgow Pollok) However, on the NHS and our public services, we are choosing to invest in those public services, as opposed - Speech Link
2: Marra, Michael (Lab - North East Scotland) cancer care in north-east Scotland. - Speech Link
3: Yousaf, Humza (SNP - Glasgow Pollok) cancer and, indeed, any other condition takes place as close to home as possible. - Speech Link
Mentions:
1: Victoria Atkins (Con - Louth and Horncastle) , during and after pregnancyWe will continue to deliver NHS England’s three-year plan for maternity services - Speech Link
Mentions:
1: Lloyd Russell-Moyle (LAB - Brighton, Kemptown) What steps she is taking to improve access to mental health services. - Speech Link
2: Ashley Dalton (Lab - West Lancashire) The two-week target from GP referral to a first consultant appointment for breast cancer has not been - Speech Link
3: Victoria Atkins (Con - Louth and Horncastle) Lady raises the important issue of breast cancer, and the NHS has an ambition to diagnose 75% of cancers - Speech Link
4: Jeremy Quin (Con - Horsham) Lobular breast cancer treatment must be improved. - Speech Link
Feb. 27 2009
Source Page: Table showing Third Sector Investment Programme 2009-10 : organisations with applications declined at Stage 1, broken down by organisation. 11 p.Found: UKBPDWORLDBreakthrough Breast CancerBreakthrough UK Ltd (2 applications)Breast Cancer Care (2 applications
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to promote screening for breast cancer to people who are eligible.
Answered by Will Quince
The Government is committed to supporting and improving the National Health Service breast screening programme. The Department has invested £10 million funding into the NHS Breast Screening Programme providing 28 new breast screening units targeted at areas with the greatest challenges of uptake and coverage. This will provide extra capacity for services to recover from the impact of the pandemic, boost uptake of screening in areas where attendance is low, tackle health disparities and contribute towards higher early diagnosis rates in line with the NHS Long Term Plan.
In addition, steps are being taken to remove barriers to attending breast cancer screening such as promoting the use of text message alerts to remind women of upcoming appointments. NHS Breast Screening Providers are also being encouraged to work with cancer alliances, primary care networks, NHS England regional teams and the voluntary sector, to bring together work to promote uptake of breast screening and take action to ensure as many people as possible can access services.